BELLEVUE GROUP AG – Vertex Pharmaceuticals Incorporated Transaction History
BELLEVUE GROUP AG portfolio value:
$335.32M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.53% | -18.01K shares | 3.9M | $289.54 | 1.15M |
Q2 2022 | share | Decrease | -20.54% | -304.11K shares | -54.87M | $281.79 | 1.17M |
Q1 2022 | share | Decrease | -17.39% | -311.50K shares | -7.16M | $260.97 | 1.48M |
Q4 2021 | share | Increase | +1.71% | 30.14K shares | 73.93M | $222.45 | 1.79M |
Q3 2021 | share | Increase | +1.61% | 27.92K shares | -30.02M | $181.39 | 1.76M |
Q2 2021 | share | Increase | +25.93% | 356.99K shares | 53.72M | $201.63 | 1.73M |
Q1 2021 | share | Increase | +11.12% | 137.71K shares | 3.01M | $214.89 | 1.37M |
Q4 2020 | share | Increase | +28.98% | 278.38K shares | 31.42M | $236.34 | 1.23M |
Q3 2020 | share | Decrease | -2.24% | -22K shares | -23.86M | $272.12 | 960.6K |
Q2 2020 | share | Decrease | -22.82% | -290.48K shares | -17.67M | $290.31 | 982.6K |
Q1 2020 | share | Decrease | -8.36% | -116.2K shares | -1.25M | $237.95 | 1.27M |
Q4 2019 | share | Decrease | -2.79% | -39.85K shares | 62.06M | $218.95 | 1.38M |
Q3 2019 | share | Increase | +0.61% | 8.65K shares | -18.36M | $169.42 | 1.42M |
Q2 2019 | share | Increase | +1114.21% | 1.30M shares | 238.96M | $183.38 | 1.42M |
Q1 2019 | share | Increase | +2.00% | 2.28K shares | 2.51M | $183.95 | 116.98K |
Q4 2018 | share | Increase | +183.25% | 74.20K shares | 11.20M | $165.71 | 114.7K |
Q3 2018 | share | Decrease | -4.26% | -1.8K shares | 617K | $192.74 | 40.49K |
Q2 2018 | share | Decrease | -56.31% | -54.51K shares | -8.59M | $169.96 | 42.29K |
Q1 2018 | share | Increase | +0.62% | 600 shares | 1.36M | $162.98 | 96.81K |
Q4 2017 | share | Increase | +60.89% | 36.41K shares | 5.32M | $149.86 | 96.21K |
Q3 2017 | share | Decrease | -12.57% | -8.6K shares | 277K | $152.04 | 59.8K |
Q2 2017 | share | Decrease | -10.00% | -7.6K shares | 505K | $128.87 | 68.4K |
Q1 2017 | share | Decrease | -6.17% | -5K shares | 2.34M | $109.35 | 76K |
Q4 2016 | share | Decrease | -4.71% | -4K shares | -1.44M | $73.67 | 81K |
Q3 2016 | share | Increase | +28.79% | 19K shares | 1.73M | $87.21 | 85K |
Q2 2016 | share | 0.00% | 0 shares | 431K | $86.02 | 66K | |
Q1 2016 | share | Increase | 0.00% | 66K shares | 5.24M | $79.49 | 66K |